Welcome to our dedicated page for Medical Prop SEC filings (Ticker: MPW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Medical Properties Trust, Inc. (NYSE: MPW) SEC filings page provides access to the company’s official regulatory disclosures as a self-advised real estate investment trust focused on net-leased hospital facilities. Formed in 2003 and incorporated in Maryland, Medical Properties Trust files reports and current disclosures with the U.S. Securities and Exchange Commission in connection with its common stock listed on the New York Stock Exchange under the symbol MPW.
Through this page, users can review key filings such as Form 10-K annual reports, which typically include detailed information on the company’s healthcare real estate portfolio, general acute, behavioral health and post-acute facilities, geographic exposure across the United States and international markets, capital structure, risk factors and management’s discussion and analysis. Form 10-Q quarterly reports provide interim updates on revenues from rent billed, straight-line rent, income from financing leases, interest and other income, as well as expenses, impairment charges, joint venture performance and balance sheet changes.
Investors can also examine Form 8-K current reports, where Medical Properties Trust discloses material events such as quarterly earnings releases, approval of a stock repurchase program, and other significant corporate actions. For example, Form 8-K filings in 2025 reference press releases announcing financial results for specific quarters and the authorization of a common stock repurchase program. In addition, filings may include exhibits with supplemental information packages and investor presentations.
Alongside traditional document access, this page highlights AI-powered tools that summarize lengthy filings, explain complex sections and surface important items such as changes in rent collections, impairment charges, financing transactions and capital allocation decisions. Users can quickly identify relevant sections of 10-Ks, 10-Qs and 8-Ks, and track how Medical Properties Trust reports on its hospital real estate portfolio, debt profile and shareholder-related actions over time.
Medical Properties Trust Inc ownership disclosure: The Vanguard Group filed a Schedule 13G/A reporting 0 shares beneficially owned, representing 0% of Common Stock following an internal realignment.
The filing explains that certain Vanguard subsidiaries or business divisions will report beneficial ownership separately in reliance on SEC Release No. 34-39538, and that Vanguard no longer is deemed to have beneficial ownership of securities held by those subsidiaries. The filing is signed by Ashley Grim, Head of Global Fund Administration.
Williams Rosa Handley reported acquisition or exercise transactions in this Form 4 filing.
MEDICAL PROPERTIES TRUST INC reported that SVP of Operations Rosa Handley Williams received two equity awards of common stock totaling 63,750 shares on March 18, 2026. After these grants, she holds 452,774 shares directly.
One award of 42,500 shares vests in equal installments at the beginning of each of 12 calendar quarters starting April 1, 2026. The other 21,250-share award is performance-based and will be earned only if specific debt reduction and cash revenue growth targets set by the compensation committee are met over the period from January 1, 2026 through December 31, 2028. The actual number of performance shares ultimately issued will depend on achievement of these thresholds, including the opportunity to earn up to one third of the award for 2026 performance.
Medical Properties Trust Inc reported that SVP and Senior Advisor to the CEO Larry H. Portal acquired a total of 112,500 shares of common stock as equity awards. One grant of 75,000 shares vests in equal installments at the beginning of each of 12 calendar quarters starting April 1, 2026. A second award of 37,500 shares is performance-based and will be earned over the period from January 1, 2026 through December 31, 2028 based on specific debt reduction and cash revenue growth thresholds set by the compensation committee, with the actual shares issued varying according to performance.
MEDICAL PROPERTIES TRUST INC senior vice president of finance and treasurer Charles R. Lambert reported stock-based compensation awards. He acquired 50,000 shares of common stock at no cost and then an additional 25,000 shares, bringing his direct holdings to 392,401 shares after the second grant.
The 50,000-share award vests in equal installments at the beginning of each of the 12 calendar quarters starting on April 1, 2026. The 25,000-share award is performance-based and will be earned over the period from January 1, 2026 through December 31, 2028, depending on specific thresholds for overall debt reduction and cash revenue growth set by the compensation committee, with up to one third tied to 2026 performance.
Hanna James Kevin reported acquisition or exercise transactions in this Form 4 filing.
Medical Properties Trust granted equity awards to Senior VP, Controller & CAO James Kevin Hanna. He received 75,000 shares of common stock as a time-based award and 37,500 performance-based shares tied to debt reduction and cash revenue growth from January 1, 2026 through December 31, 2028. Following these grants, he directly holds 546,794 shares of common stock. The time-based shares vest in equal installments at the beginning of each of 12 calendar quarters starting April 1, 2026, while the performance award will be earned only if specific performance thresholds are achieved.
Medical Properties Trust, Inc. reported sharply improved results for 2025, moving from a large prior-year loss to a much smaller one while stabilizing its hospital real estate portfolio. Net income for the fourth quarter was $17 million, or $0.03 per share, compared with a net loss of $413 million, or $(0.69) per share, a year earlier. For the full year, the company recorded a net loss of $277 million, or $(0.46) per share, versus a $2.4 billion loss, or $(4.02) per share, in 2024, reflecting far lower impairment charges.
Normalized funds from operations, a key REIT cash-flow metric, were $106.6 million, or $0.18 per share, for the fourth quarter, essentially flat with the prior year, and $346.3 million, or $0.58 per share, for 2025, down from $482.7 million, or $0.80 per share, in 2024. The company highlighted progress repositioning challenged tenants, including new long-term leases and asset sales, and reiterated a goal of driving pro forma annualized cash rent from its current portfolio to at least $1 billion by the end of 2026.
MPT ended 2025 with total assets of $15.0 billion and debt, net of issuance costs and discounts, of $9.7 billion, resulting in financial leverage of 59.0% and an adjusted net debt to annualized EBITDAre ratio of 8.5x. The portfolio comprised 384 properties and approximately 39,000 licensed beds across nine countries, with general acute care hospitals representing the majority of assets and revenue.
Medical Properties Trust, Inc. filed an 8-K to detail upcoming branding changes. The company’s New York Stock Exchange stock ticker will change from “MPW” to “MPT”, with trading under the new symbol beginning on February 2, 2026. Its common stock will remain listed on the NYSE and the CUSIP number will stay the same, so only the trading symbol is changing. The company also confirmed the previously planned relocation of its headquarters within Alabama to 10500 Liberty Parkway, Birmingham, Alabama 35242. These updates were announced in a press release furnished as an exhibit.
Medical Properties Trust director Emily Webster Murphy reported a new equity grant. On January 8, 2026, she was awarded 30,303 shares of common stock at a price of $0.00 per share, increasing her holdings to 105,828 shares held directly after the transaction.
The grant is subject to a vesting schedule. According to the filing, these shares vest in equal installments at the beginning of each of 12 calendar quarters, starting on April 1, 2026, meaning the award will vest over a three-year period if service conditions are met.
Medical Properties Trust director receives stock-based award. Director Stewart Michael G reported an award of 30,303 shares of Medical Properties Trust common stock on January 8, 2026, at a stated price of $0 per share, indicating this is an equity compensation grant rather than an open-market purchase.
After this grant, he beneficially owns 187,403 shares in total. According to the filing, these granted shares vest in equal installments at the beginning of each of the 12 calendar quarters starting on April 1, 2026, creating a multi-year vesting schedule that ties the award to ongoing service with the company.
Medical Properties Trust director reports stock award
Director Thompson C. Reynolds III reported receiving 30,303 shares of Medical Properties Trust common stock on January 8, 2026. The reported price of $0 per share indicates this was an equity award rather than an open-market purchase. Following this grant, he beneficially owns 108,795 shares, held directly.
The award is structured to vest over time. According to the filing, the shares vest in equal installments at the beginning of each of the 12 calendar quarters starting on April 1, 2026, aligning director compensation with the company’s longer-term performance.